To investigate the underlying mechanism of EPHB3 as an effective prognostic marker in CRC patients, we transfected DLD1 cells with an EPHB3 expression plasmid and found that overexpression of EPHB3 attenuated the growth and migration of these cells. The gene discussed is EPHB3; the disease is colorectal carcinoma.